Major Pharmaceuticals recalls

All Major Pharmaceuticals recalls we track from FDA, CPSC and NHTSA data. Categories: drugs (12).

12 recalls published between July 29, 2026 and July 29, 2026. Most common issues: potency (12).

• Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 150 mcg (0.0150 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 125 mcg (0.0125 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 112 mcg (0.0112 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 88 mcg (0.088 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 75 mcg (0.075 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 50 mcg (0.050 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II
• Levothyroxine Sodium Tablets, USP, 25 mcg (0.025 mg)… recall
  FDA July 29, 2026 · Major Pharmaceuticals · Class II